Compound Q&A

What is the market or research trend for Retinal (CAS: 116-31-4)?

Answer

Retinal
The market for Retinal (CAS: 116-31-4) is driven by its applications in pharmaceuticals, particularly in ophthalmology for treating retinal disorders. Research trends focus on understanding its role in vision and its potential in gene therapy and neurodegenerative diseases. The market is expected to grow due to increasing demand and novel therapeutic applications.

About

CAS No 116-31-4
English Name Retinal
Molecular Formula C20H28O
Molecular Weight 284.44 g/mol
SMILES O=C/C=C(/C=C/C=C(/C=C/C1=C(C)CCCC1(C)C)\C)\C
InChIKey NCYCYZXNIZJOKI-OVSJKPMPSA-N
Last Updated: 2025-09-06 09:47

Related Q&A

Compound Q&A

What regulatory guidelines apply to Retinal (CAS: 116-31-4)?

Retinal (CAS: 116-31-4) is regulated under the Globally Harmonized System of Classification and Labe...

Compound Q&A

Are there alternatives to Retinal (CAS: 116-31-4) in synthesis?

Alternatives to Retinal (CAS: 116-31-4) in synthesis include related retinoids such as all-trans ret...

Compound Q&A

How should waste containing Retinal (CAS: 116-31-4) be handled?

Waste containing Retinal (CAS: 116-31-4) should be collected in appropriate containers and disposed ...

Compound Q&A

What is 6-Methyl-7-oxabicyclo[4.1.0]heptan-2-one (CAS: 21889-89-4)?

6-Methyl-7-oxabicyclo[4.1.0]heptan-2-one is a cyclic ketone with a molecular for...

21889-89-46-Methyl-7-oxabicycl...
Compound Q&A

What is 4-[(6-Methyl-2-pyrazinyl)oxy]benzoic acid (CAS: 906353-00-2)?

4-[(6-Methyl-2-pyrazinyl)oxy]benzoic acid is a chemical compound with the CAS nu...

906353-00-24-[(6-Methyl-2-pyraz...
Compound Q&A

What is 2-(2-Pyridinyl)-1,3-propanediol (CAS: 49745-42-8)?

2-(2-Pyridinyl)-1,3-propanediol (CAS: 49745-42-8) is a colorless to slightly yel...

49745-42-82-(2-Pyridinyl)-1,3-...
Compound Q&A

What is 2-(6-Chloro-2-pyridinyl)-2-phenylacetonitrile (CAS: 24783-42-4)?

2-(6-Chloro-2-pyridinyl)-2-phenylacetonitrile is an organic compound with the CA...

24783-42-42-(6-Chloro-2-pyridi...